Erratum: Liver transplantation for hepatocellular carcinoma: Hangzhou experiences (Transplantation (2008) 85 (1726-1732) DOI: 10.1097/TP.0b013e31816b67e4);Liver transplantation for hepatocellular carcinoma: Hangzhou experiences

Transplantation

Volumn 85, Issue 12, 2008, Pages 1726-1732

  Zheng, Shu Sen ^a   Xu, Xiao ^a   Wu, Jian ^a   Chen, Jun ^a   Wang, Wei Lin ^a   Zhang, Min ^a   Liang, Ting Bo ^a   Wu, Li Ming ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Hepatocellular carcinoma; Liver transplantation

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; TUMOR RECURRENCE; TUMOR VOLUME; CHINA; ETHNOLOGY; KAPLAN MEIER METHOD; LIVER; LIVER TUMOR; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CHINA; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 49149114543     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000002822     Document Type: Erratum

References (26)

1. Tan KC. Liver transplantation for hepatocellular carcinoma: How far can we push the envelope? Singapore Med J 2003; 44: 309.
2. Steinmuller T, Jonas S, Neuhaus P. Review article: Liver transplantation for hepatocellular carcinoma. Aliment Pharmacol Ther 2003; 17(suppl 2): 138.
3. Molmenti EP, Klintmalm GB. Liver transplantation in association with hepatocellular carcinoma: An update of the International Tumor Registry. Liver Transpl 2002; 8: 736.
4. Zheng SS,XuX,Liang TB,et al. Liver transplantation for hepatocellular carcinoma: Prognostic analysis of 89 cases. Zhonghua Wai Ke Za Zhi 2005; 43: 450.
5. Zheng SS, Chen YM, Liang TB, et al. Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis. Liver Transpl 2006; 12: 253.
6. Jain A, Reyes J, Kashyap R, et al. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg 2000; 232: 490.
7. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med 1996; 334: 693.
8. Regalia E, Coppa J, Pulvirenti A, et al. Liver transplantation for small hepatocellular carcinoma in cirrhosis: Analysis of our experience. Transplant Proc 2001; 33: 1442.
9. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: Comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver transpl 2002; 8: 765.
10. Figueras J, Jaurrieta E, Valls C, et al. Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: Outcomes based on indicated treatment strategy. J Am Coll Surg 2000; 190: 566.
11. Lo CM, Fan ST. Liver transplantation for hepatocellular carcinoma. Br J Surg 2004; 91: 131.
12. Cillo U, Vitale A, Bassanello M, et al. Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg 2004; 239: 150.
13. Mak KS, Tan KC. Liver transplantation for hepatocellular carcinoma: An Asian perspective. Asian J Surg 2002; 25: 271.
14. Varela M, Sanchez W, Bruix J, et al. Hepatocellular carcinoma in the setting of liver transplantation. Liver Transpl 2006; 12: 1028.
15. Jonas S, Bechstein WO, Steinmuller T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33: 1080.
16. Iwatsuki S, Dvorchik I, Marsh JW, et al. Liver transplantation for hepatocellular carcinoma: A proposal of a prognostic scoring system. J Am Coll Surg 2000; 191: 389.
17. Xu X, Zheng SS, Liang TB, et al. Orthotopic liver transplantation for patients with hepatocellular carcinoma complicated by portal vein tumor thrombi. Hepatobiliary Pancreat Dis Int 2004; 3: 341.
18. Schwartz M. Liver transplantation in patients with hepatocellular carcinoma. Liver Transpl 2004; 10(2 suppl 1): S81.
19. Fernandez JA, Robles R, Marin C, et al. Can we expand the indications for liver transplantation among hepatocellular carcinoma patients with increased tumor size? Transplant proc 2003; 35: 1818.
20. Grasso A, Stigliano R,Morisco F,et al. Liver transplantation and recurrent hepatocellular carcinoma: Predictive value of nodule size in a retrospective and explant study. Transplantation 2006; 81: 1532.
21. Esnaola NF, Lauwers GY, Mirza NQ, et al. Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg 2002; 6: 224.
22. Mejia GA, Gomez MA, Serrano J, et al. Correlation between the radiologic and histologic size of hepatocellular carcinoma in patients eligible for liver transplantation. Transplant Proc 2006; 38: 1394.
23. Del Gaudio M, Grazi GL, Principe A, et al. Influence of prognostic factors on the outcome of liver transplantation for hepatocellular carcinoma on cirrhosis: A univariate and multivariate analysis.Hepatogastroenterology 2004; 51: 510.
24. Ochiai T, Sonoyama T, Ichikawa D, et al. Poor prognostic factors of hepatectomy in patients with respectable small hepatocellular carcinoma and cirrhosis. J Cancer Res Clin Oncol 2004; 130: 197.
25. De Carlis L, Giacomoni A, Pirotta V, et al. Surgical treatment of hepatocellular cancer in the era of hepatic transplantation. J Am Coll Surg 2003; 196: 887.
26. Shao ZX, Xu X, Zheng SS, et al. Serum alpha-fetoprotein alterations and tumor recurrence after liver transplantation for hepatocellular carcinoma patients. Chin J Gen Surg 2006; 21: 351.